Patients Mainly Prefer AI as Second Reader for Screening Mammogram
By Elana Gotkine HealthDay Reporter
WEDNESDAY, April 23, 2025 -- Use of artificial intelligence (AI) as a second reader in screening mammography is accepted by patients, according to a study published online April 18 in Radiology: Imaging Cancer.
B. Bersu Ozcan, M.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues conducted a prospective study involving 518 patients undergoing mammography screening between February and August 2023 who were offered a 29-question survey. Independent factors associated with participants' acceptance of AI use were examined.
The researchers found that 76.5 percent of participants reported no or minimal knowledge of AI. Overall, 4.44 percent accepted stand-alone AI interpretation, while 71.0 percent preferred AI to be used as a second reader. Most participants (88.9 percent) requested radiologist review after an AI-reported abnormality, compared with 51.3 percent who requested radiologist recall review by AI. A higher number of participants would undergo diagnostic examination for radiologist recalls versus AI recalls in cases of discrepancy, although the difference was not significant (94.2 versus 92.6 percent). Greater AI acceptance was seen in association with higher education (odds ratio, 2.05). Concern for bias was seen in association with race and was higher in Hispanic and non-Hispanic Black versus non-Hispanic White participants (odds ratios, 3.32 and 4.31, respectively).
"Our results indicate a cautious optimism among participants about the integration of AI in mammogram interpretation," the authors write.
One author disclosed ties to the publishing and medical device industries and holds a related patent.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.